Tier 3 · Filer Universe

LENZ Therapeutics, Inc.

LENZ · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$5.96
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001815776
Liquidity rank
#3231
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$19.09M2025-12-310001815776-26-000011
Annual diluted EPS-2.852025-12-310001815776-26-000011
Quarterly revenue$5.49M2026-06-300001815776-26-000052
Quarterly diluted EPS-1.022026-06-300001815776-26-000052

SEC EDGAR Frames batch generated 2026-09-08T00:39:23.526Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerMRK · Tier 1 peerPFE · Tier 1 peer

Provenance